Literature DB >> 9054403

Equilibrium intermediates in the reversible unfolding of firefly (Photinus pyralis) luciferase.

R Herbst1, U Schäfer, R Seckler.   

Abstract

Firefly luciferase has been used as a model protein to study cotranslational and chaperone-assisted protein folding. We found conditions for reversible unfolding of luciferase in the absence of cellular factors, and we characterized denaturant-induced equilibrium unfolding transitions and refolding kinetics of the enzyme. Luciferase unfolding induced by guanidinium chloride at 10 degrees C can be described as a four-state equilibrium with two inactive intermediates highly populated around 1 and 3 M denaturant. The transitions occur around 0.3, 1.7, and 3.8 M denaturant. The free energy of denaturation to the first inactive intermediate (DeltaG0N <==> I1 = 15 +/- 3 kJ.mol-1) is small for a protein of 60 kDa. Fluorescence and circular dichroism spectra of the intermediates indicate that I1 has a compact conformation, whereas aromatic side chains are highly exposed in the second intermediate, I2, despite its high content of secondary structure. In the presence of a hydrophilic detergent, significant reactivation of luciferase is observed up to temperatures at which the native protein is unstable. Reactivation kinetics of luciferase are exceedingly slow and probably not limited by proline isomerization, as suggested by their independence from the time spent in the unfolded state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054403     DOI: 10.1074/jbc.272.11.7099

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Identification of a redox-regulated chaperone network.

Authors:  Jörg H Hoffmann; Katrin Linke; Paul C F Graf; Hauke Lilie; Ursula Jakob
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

2.  Transient interactions of a slow-folding protein with the Hsp70 chaperone machinery.

Authors:  Ashok Sekhar; Margarita Santiago; Hon Nam Lam; Jung Ho Lee; Silvia Cavagnero
Journal:  Protein Sci       Date:  2012-06-11       Impact factor: 6.725

3.  Interaction of the N-terminal domain of Escherichia coli heat-shock protein ClpB and protein aggregates during chaperone activity.

Authors:  Naoki Tanaka; Yasushi Tani; Hiroyuki Hattori; Tomoko Tada; Shigeru Kunugi
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

4.  Effective cotranslational folding of firefly luciferase without chaperones of the Hsp70 family.

Authors:  Maxim S Svetlov; Aigar Kommer; Vyacheslav A Kolb; Alexander S Spirin
Journal:  Protein Sci       Date:  2005-12-29       Impact factor: 6.725

5.  The Hsp70 chaperone system maintains high concentrations of active proteins and suppresses ATP consumption during heat shock.

Authors:  Bin Hu; Masaru Tomita
Journal:  Syst Synth Biol       Date:  2007-01-26

Review 6.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

7.  Competing Pathways and Multiple Folding Nuclei in a Large Multidomain Protein, Luciferase.

Authors:  Zackary N Scholl; Weitao Yang; Piotr E Marszalek
Journal:  Biophys J       Date:  2017-05-09       Impact factor: 4.033

8.  Comparing the functional properties of the Hsp70 chaperones, DnaK and BiP.

Authors:  Jeanne Bonomo; John P Welsh; Karthish Manthiram; James R Swartz
Journal:  Biophys Chem       Date:  2010-04-10       Impact factor: 2.352

9.  Hsp72 chaperone function is dispensable for protection against stress-induced apoptosis.

Authors:  Ari M Chow; Rohan Steel; Robin L Anderson
Journal:  Cell Stress Chaperones       Date:  2008-09-26       Impact factor: 3.667

10.  Mitochondrial peroxiredoxin functions as crucial chaperone reservoir in Leishmania infantum.

Authors:  Filipa Teixeira; Helena Castro; Tânia Cruz; Eric Tse; Philipp Koldewey; Daniel R Southworth; Ana M Tomás; Ursula Jakob
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.